Japan Inflammatory Bowel Disease Market Segmentation, Forecast, Analysis, Industry Size and Share to 2025

Japan IBD market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The market is mainly driven due to the growing prevalence of IBD in the country owing to increasing smoking habits. Smoking is one of the major environmental factors leading to an adverse effect on the small and large intestines.

In fact, Crohn's disease is associated positively with smoking while ulcerative colitis is not. Moreover, smoking has a detrimental effect on the clinical course of Crohn's disease. Therefore, smoking is supporting the prevalence of Crohn's disease, which as a result is propelling the IBD market in Japan. Moreover growing research on the IBD in the country further provides substantial opportunity to the market in the near future.

Request a Free Sample of our Report on Japan Inflammatory Bowel Disease Market: https://www.omrglobal.com/request-sample/japan-ibd-inflammatory-bowel-disease-market

Japan IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Japan IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. On the basis of diagnostics, the market is segmented into blood and stool, endoscopies, ultrasound, and X-rays.

Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A Full Report of Japan Inflammatory Bowel Disease Market is Available at https://www.omrglobal.com/industry-reports/japan-ibd-inflammatory-bowel-disease-market

Japan IBD Market Segmentation

By Disease Type
o Ulcerative Colitis
o Crohn's Disease

By Diagnostics
o Blood and Stool Tests
o Endoscopies,
o Ultrasound
o X-Ray

By Therapeutics
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others

Company Profiles
o AbbVie Inc.
o Allergan, PLC
o Boehringer Ingelheim International GmbH
o Daiichi Sankyo Co. Ltd.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Mercator Pharmaceutical Solutions
o Pfizer Inc.
o RPG Life Sciences Ltd.
o Sanofi S.A.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/japan-ibd-inflammatory-bowel-disease-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.